Structural Formula (Tir03 0000 01)
Tirofiban Hydrochloride Injection, Solution
Product Images NDC 25021-417
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tirofiban Hydrochloride (NDC 25021-417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Tir03 0000 02)
Not available.*
Package Label – Principal Display Panel – Bag Label (Tir03 0000 03)
This text provides information about a medication called Tirofiban Hydrochloride Injection, containing 12.5 mg per 250 mL (50 mcg per mL). It is a sterile, nonpyrogenic, and preservative-free solution stored in a PVC-free container. The solution includes tirofiban hydrochloride, sodium chloride, sodium citrate dihydrate, citric acid anhydrous, and water for injection. The usual dosage is intravenously as directed by a physician, and caution is advised against adding supplementary medication. The storage recommendations include storing at 25°C and protecting from light. It is a single-dose container manufactured by SAGENT Pharmaceuticals and made in India, suitable for use with a calibrated infusion device for intravenous use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
